Moscow: Coronavir of Russia R-Pharm has been approved for such patients. In which the symptoms of Covid-19 are less and those who are undergoing treatment outside the hospital. The company has announced that antiviral drugs will be available at the pharmacy next week. Coronavir is approved as a prescription drug. Earlier in May the Russian drug Avifavir was approved. With the announcement of R-Pharm, it is also clear that a country like Russia does not want to lose the opportunity to stay ahead in the global race against the virus.
The test on 168 people in the third phase trial is
based on both drugs favipiravir which has been developed by Japan. It is used there to treat viral infections. R-Pharm reports that the drug was tested on 168 people in its third phase of clinical trials. In July it was allowed to be used in the hospital.
Talking to pharmacies R-Pharm A
company spokesperson said R-Pharm has started talking to pharmacies about its order and delivery could take place next week. Avifavir has been available in hospitals since June but has not yet been given in pharmacies.
The vaccine may be in November
, the Sovereign Wealth Funds of Russia The Russian Direct Investment Fund (RDIF) corona virus vaccine in India have joined hands with doreddijha lab for clinical trials and distribution of Sputnik V. Based on the agreement reached between the two companies, RDIF will supply 100 million doses of the vaccine to the Indian company. RDIF CEO Kirill Dmitriev told ET that the Sputnik V vaccine is based on the adenoviral vector platform. If successful, it will be available in India by November.
No comments:
Post a Comment